Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envarsus versus Advagraf pharmacokinetic crossover study in de novo liver transplant recipients
2015-002935-16Phase 3Completed
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Sep 2015
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tacrolimus in Post-Transplant Immunosuppression (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoints: Dav, C0/dosei and 1 more. Started Sep 2015; status: completed.
02
Drugs
tacrolimus
03
Conditions
Post-Transplant Immunosuppression
Beyond the preview
Go deeper on 2015-002935-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002935-16.